Actively Recruiting
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Led by University of Minnesota · Updated on 2025-07-20
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to examine cervical cancer screening and endometrial sampling rates in transgender and gender diverse individuals before they undergo gender-affirming hysterectomy. It seeks to assess the necessity of these tests in this population and explore patient-centered testing options. The study will provide preliminary data on current care practices and help guide future evidence-based guidelines. The study is observational, with no intervention being tested. It will observe standard of care cancer screening practices and consider the impact of HPV self-testing on screening rates and patient experience. Participants include those who have had or plan to have a hysterectomy. Participants will be assessed for their history of cancer screening and experiences with HPV self-testing. Researchers will measure rates of cervical cancer screening and endometrial sampling over 36 months, along with how HPV self-testing affects these rates and patient experience. Data will contribute to understanding guideline adherence and patient preferences in this community.
CONDITIONS
Brief Title
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years and older
- Able to provide voluntary written consent prior to any research activity
- Able to understand, speak, read, and write in English
- Patients who have undergone or plan to undergo hysterectomy
- Patients who are transgender and gender diverse
You will not qualify if you...
- Opted out of research
- Younger than 18 years
- Lacks capacity to consent or has diminished capacity to consent
- Cannot provide informed consent
- Members of the study's community advisory board
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 36 months
Participants who undergo routine care are observed for cervical and endometrial cancer screening outcomes.
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneota, Minnesota, United States, 55455
Actively Recruiting
Research Team
M
Maria Bunch
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here